Skip to content
10-Q

Quarterly Report

CNBX PHARMACEUTICALS INC. CNBX

0001683168-24-000255

← back to feed
Filed
Jan 12, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2024 · Jan 12, 2024 31.11M sh
Cash And Equivalents Q1 2024 · Nov 30, 2023 $81.65K
Cash And Equivalents Q1 2024 · Aug 31, 2023 $129.7K
Current Liabilities Q1 2024 · Nov 30, 2023 $2.48M
Current Liabilities Q1 2024 · Aug 31, 2023 $2.52M
Current Assets Q1 2024 · Nov 30, 2023 $150.94K
Current Assets Q1 2024 · Aug 31, 2023 $224.31K
Total Assets Q1 2024 · Nov 30, 2023 $387.4K
Total Assets Q1 2024 · Aug 31, 2023 $499.04K
Shares Diluted Q1 2024 · Nov 30, 2022 1.26M sh
Operating Cash Flow Q1 2024 · Nov 30, 2022 −$95.92K
Stockholders Equity Q1 2024 · Nov 30, 2022 −$1.97M
Stockholders Equity Q1 2024 · Aug 31, 2022 −$1.63M
Eps Diluted Q1 2024 · Nov 30, 2022 −$0.33
Eps Basic Q1 2024 · Nov 30, 2022 −$0.33
Sga Expense Q1 2024 · Nov 30, 2022 $283.9K
Rd Expense Q1 2024 · Nov 30, 2022 $62.89K
Net Income Q1 2024 · Nov 30, 2022 −$357.67K
Operating Income Q1 2024 · Nov 30, 2022 −$346.79K
Revenue Q1 2024 · Nov 30, 2022 $0